Infections in Kidney and Pancreas Transplantation

Megan K. Morales,Matthew Cooper,Peter Abrams,Joseph G. Timpone

DOI: https://doi.org/10.1007/978-1-4939-9034-4_4

2019-01-01

Abstract:The optimal treatment for patients with chronic kidney disease (CKD) requiring renal replacement therapy/dialysis is kidney transplantation. Additionally, pancreas transplantation alone or simultaneous pancreas-kidney transplantation offers improved quality of life as well as reversion or prevention of complications seen in patients with type 1 diabetes mellitus. Patients with CKD on dialysis are at increased risk for bacterial and blood-borne viral pathogens. During the initial first month posttransplantation period, kidney and kidney-pancreas transplant recipients are at increased risk for healthcare-acquired infections and complications associated with surgery. Over the next 6 months, during the period of maximal immunosuppression, these patients are at increased risk for opportunistic infections such as BK polyomavirus and cytomegalovirus. Anti-infective prophylactic strategies have been developed to decrease rates of specific opportunistic infections during this time period. Beyond 6 months, patients are at increased risk for community-acquired infections, including bacterial and fungal infections such as invasive molds, endemic mycoses, as well as the complications of chronic immunosuppressive therapy. This chapter provides a brief overview of kidney and pancreas transplantation with regard to types of transplantations, selection criteria, surgical procedures, and immunosuppressive regimens. It will then focus on infectious complications encountered in patients on dialysis and the pretransplantation evaluation for patients awaiting organs. Infectious complications that are specific to kidney and pancreas transplantation are reviewed in detail, including the role of anti-infective prophylaxis. Specific infectious etiologies and syndromes that are related to kidney and pancreas transplantation will also be presented.